Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Are neuropsychiatric symptoms modifiable risk factors for cognitive decline in Alzheimer's disease and vascular dementia?

Savulich G, O'Brien JT, Sahakian BJ.

Br J Psychiatry. 2019 Apr 30:1-3. doi: 10.1192/bjp.2019.98. [Epub ahead of print]

PMID:
31036096
2.

Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2008 Jun.

3.

Neuropsychiatric symptoms in the prodromal stages of dementia.

Stella F, Radanovic M, Balthazar ML, Canineu PR, de Souza LC, Forlenza OV.

Curr Opin Psychiatry. 2014 May;27(3):230-5. doi: 10.1097/YCO.0000000000000050. Review.

PMID:
24613979
4.

Association of cerebral emboli with accelerated cognitive deterioration in Alzheimer's disease and vascular dementia.

Purandare N, Burns A, Morris J, Perry EP, Wren J, McCollum C.

Am J Psychiatry. 2012 Mar;169(3):300-8. doi: 10.1176/appi.ajp.2011.11010009. Erratum in: Am J Psychiatry. 2012 Mar 1;169(3):338.

PMID:
22193532
5.

Neuropsychiatric symptoms in patients with Alzheimer's disease with a vascular component.

Bidzan M, Bidzan L, Pachalska M.

Ann Agric Environ Med. 2014;21(2):412-5. doi: 10.5604/1232-1966.1108615.

6.

Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): study protocol for a randomized controlled trial.

Forstmeier S, Maercker A, Savaskan E, Roth T.

Trials. 2015 Nov 17;16:526. doi: 10.1186/s13063-015-1043-0.

7.

A comparison of psychiatric symptoms in vascular dementia and Alzheimer's disease.

Sultzer DL, Levin HS, Mahler ME, High WM, Cummings JL.

Am J Psychiatry. 1993 Dec;150(12):1806-12.

PMID:
8238634
8.

Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment.

McMaster M, Kim S, Clare L, Torres SJ, D'Este C, Anstey KJ.

Clin Interv Aging. 2018 Nov 21;13:2397-2406. doi: 10.2147/CIA.S182046. eCollection 2018.

9.

Neuropsychiatric symptoms in Alzheimer disease and cognitively impaired, nondemented elderly from a community-based sample in Brazil: prevalence and relationship with dementia severity.

Tatsch MF, Bottino CM, Azevedo D, Hototian SR, Moscoso MA, Folquitto JC, Scalco AZ, Louzã MR.

Am J Geriatr Psychiatry. 2006 May;14(5):438-45.

PMID:
16670248
10.

Effects of cognitive stimulation on neuropsychiatric symptoms in elderly with Alzheimer's disease: A systematic review.

Fukushima RLM, do Carmo EG, Pedroso RDV, Micali PN, Donadelli PS, Fuzaro G Junior, Venancio RCP, Viola J, Costa JLR.

Dement Neuropsychol. 2016 Jul-Sep;10(3):178-184. doi: 10.1590/S1980-5764-2016DN1003003.

11.

Compensatory mechanisms in higher-educated subjects with Alzheimer's disease: a study of 20 years of cognitive decline.

Amieva H, Mokri H, Le Goff M, Meillon C, Jacqmin-Gadda H, Foubert-Samier A, Orgogozo JM, Stern Y, Dartigues JF.

Brain. 2014 Apr;137(Pt 4):1167-75. doi: 10.1093/brain/awu035. Epub 2014 Feb 27.

PMID:
24578544
12.

Comprehensive analysis of patient and caregiver predictors for caregiver burden, anxiety and depression in Alzheimer's disease.

Lou Q, Liu S, Huo YR, Liu M, Liu S, Ji Y.

J Clin Nurs. 2015 Sep;24(17-18):2668-78. doi: 10.1111/jocn.12870. Epub 2015 Jun 25.

PMID:
26108739
13.

Serotonergic drugs for the treatment of neuropsychiatric symptoms in dementia.

Magierski R, Sobow T.

Expert Rev Neurother. 2016;16(4):375-87. doi: 10.1586/14737175.2016.1155453. Epub 2016 Mar 10. Review.

PMID:
26886148
14.

Assessment of neuropsychiatric symptoms in dementia: toward improving accuracy.

Stella F.

Dement Neuropsychol. 2013 Jul-Sep;7(3):244-251. doi: 10.1590/S1980-57642013DN70300003. Review.

15.

The course of neuropsychiatric symptoms in dementia: a 3-year longitudinal study.

Brodaty H, Connors MH, Xu J, Woodward M, Ames D; PRIME study group.

J Am Med Dir Assoc. 2015 May 1;16(5):380-7. doi: 10.1016/j.jamda.2014.12.018. Epub 2015 Feb 14.

PMID:
25687925
16.

Neuropsychiatric Symptoms in Alzheimer's Disease Are the Main Determinants of Functional Impairment in Advanced Everyday Activities.

Delgado C, Vergara RC, Martínez M, Musa G, Henríquez F, Slachevsky A.

J Alzheimers Dis. 2019;67(1):381-392. doi: 10.3233/JAD-180771.

PMID:
30584142
17.

Cognitive and Neuropsychiatric Symptom Differences in Early Stages of Alzheimer's Disease: Kuopio ALSOVA Study.

Hallikainen I, Koivisto AM, Paajanen T, Hiltunen A, Karppi P, Vanhanen M, Välimäki T, Herukka SK, Soininen H, Hänninen T.

Dement Geriatr Cogn Dis Extra. 2012 Jan;2:209-18. doi: 10.1159/000338231. Epub 2012 May 5.

18.

Neuropsychiatric symptoms in Vascular Cognitive Impairment: a systematic review.

Tiel C, Sudo FK, Alves GS, Ericeira-Valente L, Moreira DM, Laks J, Engelhardt E.

Dement Neuropsychol. 2015 Jul-Sep;9(3):230-236. doi: 10.1590/1980-57642015DN93000004.

19.

Early behavioural changes in familial Alzheimer's disease in the Dominantly Inherited Alzheimer Network.

Ringman JM, Liang LJ, Zhou Y, Vangala S, Teng E, Kremen S, Wharton D, Goate A, Marcus DS, Farlow M, Ghetti B, McDade E, Masters CL, Mayeux RP, Rossor M, Salloway S, Schofield PR, Cummings JL, Buckles V, Bateman R, Morris JC; Dominantly Inherited Alzheimer Network.

Brain. 2015 Apr;138(Pt 4):1036-45. doi: 10.1093/brain/awv004. Epub 2015 Feb 15. Erratum in: Brain. 2015 Dec;138(Pt 12):e401.

20.

An Overview of Systematic Reviews of Ginkgo biloba Extracts for Mild Cognitive Impairment and Dementia.

Zhang HF, Huang LB, Zhong YB, Zhou QH, Wang HL, Zheng GQ, Lin Y.

Front Aging Neurosci. 2016 Dec 6;8:276. doi: 10.3389/fnagi.2016.00276. eCollection 2016. Review.

Supplemental Content

Support Center